Movement disorders News and Research

RSS

B cell accumulation triggers nervous system damage in MS

B cells are important in helping the immune system fight pathogens. However, in the case of the neurological autoimmune disease Multiple Sclerosis (MS) they can damage nerve tissue.

8 Nov 2018

The appendix may be associated with Parkinson’s disease

The vermiform appendix or appendix as we commonly know it, is a vestigial organ of the body which does not come into notice unless it is inflamed (such as in appendicitis). In cases of appendicitis, the finger like part of the gut at the base of the caecum is surgically removed.

1 Nov 2018

Study outlines how gut bacteria may influence behavior, including movement

A new study puts a fresh spin on what it means to "go with your gut." The findings, published in Nature, suggest that gut bacteria may control movement in fruit flies and identify the neurons involved in this response.

1 Nov 2018

Biogen and Eisai present detailed results from phase 1b study of aducanumab at CTAD meeting

Biogen and Eisai Co., Ltd. announced that Biogen presented results at the Clinical Trials on Alzheimer's Disease meeting, in Barcelona, Spain, from the recent 36- and 48-month analyses of the ongoing long-term extension of the Phase 1b study of aducanumab, an investigational treatment for mild cognitive impairment due to Alzheimer's disease and mild AD.

29 Oct 2018

Salk researchers advance sonogenetics technology for treating neurological conditions

The emerging technology of sonogenetics--a technique where cells are controlled by sound--offers the potential to one day replace pharmaceutical drugs or invasive surgical treatments for neurological conditions like epilepsy, Parkinson's disease or posttraumatic stress disorder.

23 Oct 2018

Scientists reprogram mature inhibitory neurons into dopaminergic cells

Attempting to make dopamine-producing neurons out of glial cells in mouse brains, a group of researchers instead converted mature inhibitory neurons into dopaminergic cells.

12 Oct 2018

Study: Brain's neurons are more changeable in adulthood than previously thought

UT Southwestern researchers attempting to transform supporting brain cells into neurons instead reprogrammed mature inhibitory neurons into a different type of neuron that creates the neurotransmitter lost in Parkinson's disease.

12 Oct 2018

T-CALM Phase 2 clinical study results offer hope for essential tremor patients

Cavion, Inc., a leading clinical stage biotechnology company committed to developing novel therapeutics for people with neurological diseases, today announced promising results of the T-CALM Phase 2 clinical trial of its first-in-class T-type calcium channel modulator CX-8998 in essential tremor.

7 Oct 2018

Researchers develop way to measure different types of fear of falling in patients with Parkinson’s

Parkinson's disease, a progressive nervous system disorder that affects movement, causes one of the highest risks of falling among all neurological conditions. Due to this, many patients develop a fear of falling, even if they have never fallen.

25 Sep 2018

Biogen and Eisai announce results of LTE Phase 1b study of aducanumab for treating MCI

Biogen and Eisai Co., Ltd. announced results from a recent analysis of the ongoing long-term extension Phase 1b study of aducanumab, an investigational treatment for mild cognitive impairment due to Alzheimer's disease and mild AD dementia.

24 Sep 2018

Researchers study motor, cognitive effects of DBS in patients with Parkinson's disease

Researchers from Charité - Universitätsmedizin Berlin have studied motor and cognitive effects of deep brain stimulation in patients with Parkinson's disease.

28 Aug 2018

Electrical stimulation of the brain may help treat symptoms of neurodegenerative ataxias

Electrical stimulation of the brain and spinal cord may help treat the symptoms of rare movement disorders called neurodegenerative ataxias, according to a study published in the August 22, 2018, online issue of Neurology, the medical journal of the American Academy of Neurology.

23 Aug 2018

Study: Occupational stress is associated with Parkinson's disease risk

Results from a Movement Disorders study suggest that occupational stress is associated with Parkinson's Disease risk, such that having a high-demand occupation is a risk factor and low control is protective.

22 Aug 2018

Biomarkers responsible for exhaustion in cancer linked to fatigue in Parkinson's disease

Biological markers responsible for extreme exhaustion in patients with cancer have now been linked to fatigue in those with Parkinson's disease, according to new research from Rice University.

10 Aug 2018

New treatment may be on the horizon for Parkinson's disease

More of us are susceptible to Parkinson's as we age, as evidenced by actor Alan Alda's recent diagnosis. A new treatment may be on the horizon.

2 Aug 2018

Study shows how the brain responds to disruptions in the body’s balance

A study of young adults published in eNeuro demonstrates how the brain responds to disruptions in the body’s balance. The research identifies a pattern of electrical activity that could be used to assess balance in patients with movement disorders such as Parkinson’s disease.

From Society for Neuroscience 1 Aug 2018

Parkinson's therapies being developed may benefit everybody with the disease

A gene linked to 3 to 4 percent of people with Parkinson's disease could play an important role in most, if not all, people with the disease, according to new study findings from the University of Pittsburgh School of Medicine and UPMC.

26 Jul 2018

FAU researchers find possible cause of Parkinson’s disease in the patients’ immune system

Parkinson's disease, formerly also referred to as shaking palsy, is one of the most frequent disorders affecting movement and the nervous system.

19 Jul 2018

Scientists develop unique play structure for rehabilitation of post-stroke patients

Scientists of Peter the Great St. Petersburg Polytechnic University (SPbPU) in collaboration with neurophysiologists from Sechenov Institute of evolutionary physiology and biochemistry formed the innovative startup iBrain have developed a unique play structure for post-stroke patients rehabilitation as part of Project 5-100.

6 Jul 2018

Patients with mild Alzheimer's disease over age 65 continue to derive benefit from DBS-f treatment

An age group analysis of data from the ADvance trial has shown that participants over the age of 65 continue to derive the most benefit from Deep Brain Stimulation of the fornix, as observed in the data from the phase 2 findings (12 - 24 months) of the Phase II trial.

19 Jun 2018